Chen, Junren http://orcid.org/0000-0003-3691-4931
Gale, Robert Peter http://orcid.org/0000-0002-9156-1676
Feng, Yahui
Hu, Yu
Qi, Saibing
Liu, Xueou
Zhu, Huaiping
Gong, Xiaowen
Zhang, Wei
Liu, Huilan
Sun, Zimin
Article History
Received: 22 June 2023
Revised: 29 June 2023
Accepted: 12 July 2023
First Online: 20 July 2023
Change Date: 30 August 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41375-023-02012-w
Competing interests
: RPG is a consultant to Antengene Biotech LLC, Ascentage Pharma Group and NexImmune Inc.; Medical Director, FFF Enterprises Inc.; Board of Directors: Russian Foundation for Cancer Research Support; and Scientific Advisory Boards, Nanexa AB and StemRad Ltd.
: Approved by the Academic Committee (IIT2021042) of the Institute of Hematology, Chinese Academy of Medical Sciences (IHCAMS) and the Ethics Review Committees of IHCAMS and FAHUSTC (QTJC2022026-EC-1 and 2022-RE-070). Subjects gave written informed consent consistent with precepts of the Helsinki Declaration.